Association between hemostatic markers, serum lipid fractions and progression of cerebral small vessel disease: A 2-year follow-up study

Neurologia i Neurochirurgia Polska - Tập 52 - Trang 54-63 - 2018
Jacek Staszewski1, Renata Piusińska-Macoch1, Bogdan Brodacki1, Ewa Skrobowska2, Adam Stępień1
1Clinic of Neurology, Military Institute of Medicine, Szaserow 128, Warsaw 04-141, Poland
2Department of Radiology, Military Institute of Medicine, Szaserow 128, Warsaw 04-141, Poland

Tài liệu tham khảo

Pantoni, 2010, Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges, Lancet Neurol, 9, 689, 10.1016/S1474-4422(10)70104-6 Wardlaw, 2013, Mechanisms underlying sporadic cerebral small vessel disease: insights from neuroimaging, Lancet Neurol, 12, 70060, 10.1016/S1474-4422(13)70060-7 Schmidt, 2011, Heterogeneity in age-related white matter changes, Acta Neuropathol, 122, 171, 10.1007/s00401-011-0851-x Gouw, 2008, Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study, Stroke, 39, 1414, 10.1161/STROKEAHA.107.498535 Jackson, 2005, Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts, Stroke, 36, 891, 10.1161/01.STR.0000157949.34986.30 Liao, 1997, The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular risk factors: the ARIC study, Neuroepidemiology, 16, 149, 10.1159/000368814 Longerstreth, 2005, Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study, Stroke, 36, 56, 10.1161/01.STR.0000149625.99732.69 Norden, 2011, Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol, BMC Neurol, 11, 29, 10.1186/1471-2377-11-29 Wiseman, 2015, Plasma biomarkers of inflammation, endothelial function and hemostasis in cerebral small vessel disease, Cerebrovasc Dis, 40, 157, 10.1159/000438494 Grotemeyer, 2014, Association of elevated plasma viscosity with small vessel occlusion in ischemic cerebral disease, Thromb Res, 133, 96, 10.1016/j.thromres.2013.10.028 Schilling, 2014, Plasma lipids and cerebral small vessel disease, Neurology, 11, 1844, 10.1212/WNL.0000000000000980 Staszewski, 2013, Significance of haemodynamic and haemostatic factors in the course of different manifestations of cerebral small vessel disease: the SHEF-SVD Study—Study Rationale and Protocol, Neurosci J, 9 pages Hurtig, 1993, Vascular parkinsonism, 81 Chui, 1992, Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers, Neurology, 42, 473, 10.1212/WNL.42.3.473 Zijlmans, 2004, Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis, Mov Disord, 19, 630, 10.1002/mds.20083 Wardlaw, 2013, Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration, Lancet Neurol, 12, 822, 10.1016/S1474-4422(13)70124-8 Staals, 2014, Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden, Neurology, 30, 1228, 10.1212/WNL.0000000000000837 Fazekas, 1987, MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging, AJR Am J Roentgenol, 149, 351, 10.2214/ajr.149.2.351 Pantoni, 2005, Impact of age-related cerebral white matter changes on the transition to disability: the LADIS study: rationale, design and methodology, Neuroepidemiology, 24, 51, 10.1159/000081050 Valdes Hernandez Mdel, 2013, Close correlation between quantitative and qualitative assessments of white matter lesions, Neuroepidemiology, 40, 13, 10.1159/000341859 Doubal, 2010, Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease, Stroke, 41, 450, 10.1161/STROKEAHA.109.564914 Prins, 2004, Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics, Neurology, 62, 1533, 10.1212/01.WNL.0000123264.40498.B6 Staszewski, 2017, Vascular parkinsonism and vascular dementia are associated with an increased risk of vascular events or death, Arch Med Sci Atheroscler Dis, 2, e16, 10.5114/amsad.2017.68549 Wardlaw, 2005, What causes lacunar stroke?, J Neur Neurosurg Psychiatry, 76, 617, 10.1136/jnnp.2004.039982 Schmidt, 1997, Risk factors for microangiopathy-related cerebral damage in the Austrian Stroke Prevention Study, J Neurol Sci, 152, 15, 10.1016/S0022-510X(97)00137-8 Marti-Fabregas, 2002, Fibrinogen and the amount of leukoaraiosis in patients with symptomatic small-vessel disease, Eur Neurol, 48, 185, 10.1159/000066161 Wiseman, 2014, Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis, Cerebrovasc Dis, 37, 64, 10.1159/000356789 Aribisala, 2014, Circulating inflammatory markers are associated with magnetic resonance imaging-visible perivascular spaces but not directly with white matter hyperintensities, Stroke, 45, 605, 10.1161/STROKEAHA.113.004059 Yokote, 2015, Elevated release of beta-thromboglobulin and platelet factor 4 in cerebral infarction patients with branch atheromatous disease: a preliminary report, Neurol Med Chir, 55, 809, 10.2176/nmc.rc.2015-0042 Hassan, 2003, Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis, Brain, 126, 424, 10.1093/brain/awg040 Gouw, 2008, Progression of white matter hyperintensities and incidence of new lacunes over a three-year period: the Leukoaraiosis and Disability study, Stroke, 39, 1414, 10.1161/STROKEAHA.107.498535 Carmelli, 1999, Midlife cardiovascular risk factors and brain morphology in identical older male twins, Neurology, 52, 1119, 10.1212/WNL.52.6.1119 Schmidt, 1996, Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants, Stroke, 27, 2043, 10.1161/01.STR.27.11.2043 Bezerra, 2012, Risk factors for lacune subtypes in the atherosclerosis risk in communities (ARIC) study, Neurology, 78, 102, 10.1212/WNL.0b013e31823efc42 van Dijk, 2008, Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study, Stroke, 39, 2712, 10.1161/STROKEAHA.107.513176 Mitaki, 2017, Serum lipid fractions and cerebral microbleeds in a healthy Japanese population, Cerebrovasc Dis, 43, 186, 10.1159/000456623 Wardlaw, 2013, Mechanisms underlying sporadic cerebral small vessel disease: insights from neuroimaging, Lancet Neurol, 12, 532, 10.1016/S1474-4422(13)70060-7 Mok, 2014, Risk factors as possible targets for prevention of small vessel disease Fazekas, 1993, Pathologic correlates of incidental MRI white matter signal hyperintensities, Neurology, 43, 1683, 10.1212/WNL.43.9.1683 Olsson, 2013, White matter lesion assessment in patients with cognitive impairment and healthy controls: reliability comparisons between visual rating, a manual and an automatic volumetrical MRI method – the Gothenburg MCI study, J Aging Res, 10.1155/2013/198471